New antibody treatment aims to protect transplanted kidneys from common virus
Disease control
Completed
This study tested an antibody drug called AntiBKV in 95 kidney transplant patients with BK virus infection. The virus can damage the new kidney if not controlled. Patients received four doses of the drug or a placebo over four months. The goal was to see if the drug could clear t…
Phase: PHASE2, PHASE3 • Sponsor: Memo Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC